These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 25879904)

  • 1. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: Results from the DRUCK-study.
    Derks L; Gassowski M; Nielsen S; An der Heiden M; Bannert N; Bock CT; Bremer V; Kücherer C; Ross S; Wenz B; Marcus U; Zimmermann R;
    Int J Drug Policy; 2018 Sep; 59():54-62. PubMed ID: 30005420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
    Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
    Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?
    Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Wiessing L; Colom J; Brugal MT;
    Subst Use Misuse; 2016 Jan; 51(2):250-60. PubMed ID: 26820260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
    Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
    BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
    Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
    Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
    Altawalah H; Essa S; Ezzikouri S; Al-Nakib W
    Sci Rep; 2019 Apr; 9(1):6292. PubMed ID: 31000775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
    Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
    Boodram B; Golub ET; Ouellet LJ
    Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.
    Hope VD; Harris R; McVeigh J; Cullen KJ; Smith J; Parry JV; DeAngelis D; Ncube F
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):331-7. PubMed ID: 26361173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.
    McAuley A; Palmateer NE; Goldberg DJ; Trayner KMA; Shepherd SJ; Gunson RN; Metcalfe R; Milosevic C; Taylor A; Munro A; Hutchinson SJ
    Lancet HIV; 2019 May; 6(5):e315-e324. PubMed ID: 30981674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.